Sign in

    Proto Labs Inc (PRLB)

    You might also like

    Proto Labs, Inc. (PRLB) is a leading digital manufacturer specializing in custom prototypes and on-demand production parts. The company leverages advanced manufacturing technologies, including injection molding, CNC machining, 3D printing, and sheet metal fabrication, to produce high-quality plastic, metal, and liquid silicone rubber parts. PRLB serves a diverse customer base of product developers, engineers, and supply chain professionals, offering fast and efficient solutions for bringing new ideas to market.

    1. Injection Molding - Manufactures custom plastic, metal, and liquid silicone rubber parts using advanced injection molding processes to deliver high-quality prototypes and production parts.
    2. CNC Machining - Produces precision-machined parts from a variety of materials, offering rapid turnaround for both prototypes and low-volume production.
    3. 3D Printing - Provides additive manufacturing services for creating complex and detailed parts using a range of 3D printing technologies and materials.
    4. Sheet Metal - Fabricates custom sheet metal parts for prototypes and low-volume production, supporting a variety of applications and industries.
    5. Other Revenue - Includes additional services and offerings that complement the core manufacturing processes.
    NamePositionStart DateShort Bio
    Robert BodorPresident, Chief Executive Officer, and DirectorMarch 1, 2021Robert Bodor has served as President, CEO, and Director since March 2021. He previously held roles such as VP/GM - Americas (2015–2021), CTO (2013–2015), and Director of Business Development (2012–2013).
    Daniel SchumacherChief Financial OfficerJune 3, 2022Daniel Schumacher has been CFO since June 2022. He was Interim CFO from December 2021 and VP of Investor Relations and FP&A (2017–2021). He also held finance roles at Stratasys and Rockwell Automation.
    Oleg RyaboyChief Technology OfficerSeptember 9, 2022Oleg Ryaboy has been CTO since September 2022. Before joining Proto Labs, he was CTO and SVP at Digital River (2015–2022) and VP of Software Development and Architecture (2011–2015).
    Michael R. KenisonVice President/General Manager - AmericasJune 2021Michael R. Kenison has served as VP/GM - Americas since June 2021. He was previously VP of Manufacturing (2013–2021) and held leadership roles at Cardiac Science, Inc..
    Bjoern KlaasVice President/General Manager and Managing Director - EMEADecember 2017Bjoern Klaas has been VP/GM and Managing Director - EMEA since December 2017. He previously worked at PolyOne (2012–2017) as VP/GM for its ColorMatrix Group and at Colorant-Chromatics (2008–2012) as GM.
    1. Given the deceleration in Network growth to 11% year-over-year in Q3 2024 from over 80% in Q3 2023, how do you plan to re-accelerate growth in the Network business, especially considering the ongoing contraction in manufacturing?

    2. With the closure of your prototype Injection Molding facility in Germany and discontinuation of DMLS services in Europe, how will these actions impact your European revenue and customer relationships, and what specific measures are you taking to mitigate potential revenue loss?

    3. Your gross margins have improved partly due to favorable market conditions with excess capacity in manufacturing; how sustainable are these margin improvements if market conditions tighten, and what strategic initiatives are in place to maintain margins in a more competitive environment?

    4. Despite efforts to increase revenue per customer, third quarter revenue per customer contact declined 1% year-over-year due to a decline in Injection Molding revenue; what are the underlying causes of this decline, and how do you plan to reverse it to drive growth?

    5. With the continued headwinds in your Sheet Metal service, which declined 13% year-over-year and has not grown for several quarters, what strategic decisions are you considering for this segment, and is there potential to integrate it into the Network model similar to actions taken with other services?

    Program DetailsProgram 1
    Approval DateFebruary 7, 2023
    End Date/DurationNot explicitly stated
    Total Additional Amount$50 million
    Remaining Authorization$42.5 million (as of 2024-09-30)
    DetailsIncreased total authorization to $250 million